Company: CL
Filing Date: 2025-04-30
Form Type: 424B2
Source: 0001104659-25-042488
Chunk: 6

Company: COLGATE PALMOLIVE CO
Filing Date: 2025-04-30
Form: 424B2
Chunk 6
---
 The Notes will be issued in minimum denominations of $2,000 and integral multiples of $1,000 in excess thereof. |
| Risk Factors  | See “Risk Factors” and the other information included in or incorporated by reference into this prospectus supplement and the accompanying prospectus for a discussion of factors you should carefully consider before deciding to purchase the Notes.                                                                                                                                                                                           |
| Governing Law | New York                                                                                                                                                                                                                                                                                                                                                                                                                                         |

<div align='center'>S-3

Risk Factors</div>

Your investment in the Notes involves certain risks. In consultation with your own financial, tax, accounting and legal advisers, you should carefully consider, among other matters, the factors set forth below as well as the risk factors discussed in the accompanying prospectus and in our most recent Annual Report on Form 10-K and Quarterly Report on Form 10-Q, which are incorporated by reference into this prospectus supplement and the accompanying prospectus before deciding whether to make an investment in the Notes.

Risks Related to the Notes

Our indebtedness could materially and adversely affect our ability to meet our debt service obligations under the Notes.

As of March 31, 2025, we had $8,269 million
of indebtedness outstanding on a consolidated basis. Of such indebtedness, approximately $75 million was indebtedness of our subsidiaries.
In addition, we have a $3,000 million revolving credit facility. At March 31, 2025, we had no outstanding borrowings under the revolving
credit facility.

Our level of indebtedness and the limitations imposed
on us by our debt agreements could have significant adverse consequences to holders of the Notes. Our cash flow may be insufficient to
meet our debt service obligations with respect to the Notes and our other indebtedness, which would enable the lenders and other debtholders
to accelerate the maturity of their indebtedness, or be insufficient to fund other important business uses after meeting such obligations.
We may be unable to borrow additional funds as needed or on favorable terms. We may be unable to refinance our indebtedness at maturity
or earlier acceleration, if applicable, or the refinancing terms may be less favorable than the terms of our original indebtedness or
otherwise be generally unfavorable. We may violate restrictive covenants in our debt agreements, which would entitle the lenders and other
debtholders to accelerate the maturity of their indebtedness.

If any one of these events were to occur, our business,
financial condition, liquidity, results of operations and prospects, as well as our ability to